Diffuse panbronchiolitis: role of macrolides in therapy.

Abstract

Diffuse panbronchiolitis (DPB) is characterized by chronic sinobronchial infection and diffuse bilateral micronodular pulmonary lesions consisting of inflammatory cells. Studies on disease etiology point to a genetic predisposition unique to Asians. Early therapy for DPB was largely symptomatic. The advent of macrolide antibiotics, including erythromycin… (More)

Topics

Cite this paper

@article{Keicho2002DiffusePR, title={Diffuse panbronchiolitis: role of macrolides in therapy.}, author={Naoto Keicho and Shoji Kudoh}, journal={American journal of respiratory medicine : drugs, devices, and other interventions}, year={2002}, volume={1 2}, pages={119-31} }